Skip to content

Public FDA record

Z-2798-2020: Barricaid Annual Closure Device (ACD) BAR-A8-8MM - Product Usage: The Barricaid ACD is indicated for redu

Recall record Z-2798-2020 for Intrinsic Therapeutics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2798-2020
Company in FDA record
Intrinsic Therapeutics, Inc.
FDA record creation date
Aug 13, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.

Source facts

Action
Intrinsic Therapeutics will be sending out a recall letter to all effected customers explaining the incorrect catalog number on the peelable inner label. The firm is requesting customers to quarantine any unused devices and return the completed recall acknowledgment form.
Initiated
2020-07-24
Root cause
Process control
Terminated
2020-09-16
Distribution
US Nationwide distribution.
Recall number
Z-2798-2020
Recall status
Terminated
CDRH record ID
182765
FDA record created
2020-08-13
Recall event number
86121

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗